EGFR-mutated NSCLC

Based on your current knowledge, please rate the below statements on how strongly you agree or disagree with them. 

This survey is intended for clinicians treating patients with EGFR-mutated non-small-cell lung cancer only.

Your answers are anonymous.
1.I can provide the most appropriate personalized treatment approaches for patients with EGFR-mutated NSCLC.
Definitely not
Entirely agree
2.I understand and can apply the latest data on treatment sequencing approaches for patients with EGFR-mutated NSCLC.
Definitely not
Entirely agree
3.I understand and know how to use real-world evidence to provide up to date care for patients with EGFR-mutated NSCLC.
Definitely not
Entirely agree
4.I am comfortable speaking to my patients with EGFR-mutated NSCLC about all possible treatment options.
Definitely not
Entirely agree
5.Following on from Question 4, do you think tools such as plain language material would be beneficial when speaking with your patients with EGFR-mutated NSCLC about their treatment plans?